Results 101 to 110 of about 4,421 (165)

Pathological complete response to pembrolizumab in recurrent retroperitoneal dedifferentiated liposarcoma with high tumor mutational burden: a case report. [PDF]

open access: yesWorld J Surg Oncol
Abe S   +15 more
europepmc   +1 more source

Diagnosis, Treatment, and Unmet Needs of Dedifferentiated Liposarcoma in the United States: A Multidisciplinary Delphi Study. [PDF]

open access: yesCancers (Basel)
Campbell D   +9 more
europepmc   +1 more source

Ferroptosis as a therapeutic vulnerability in MDM2 inhibition in dedifferentiated liposarcoma. [PDF]

open access: yesOncol Lett
Yen CC   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy